The third generation chemotherapy drug in combing platonic regimen or sequential regimen in advanced non-small-cell lung cancer patients age ＞70,or with performance status 2[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 203-205. DOI: 10.3969/j.issn.1671-5144.2004.04.004
|
Citation:
|
The third generation chemotherapy drug in combing platonic regimen or sequential regimen in advanced non-small-cell lung cancer patients age ＞70,or with performance status 2[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 203-205. DOI: 10.3969/j.issn.1671-5144.2004.04.004
|
The third generation chemotherapy drug in combing platonic regimen or sequential regimen in advanced non-small-cell lung cancer patients age ＞70,or with performance status 2[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 203-205. DOI: 10.3969/j.issn.1671-5144.2004.04.004
|
Citation:
|
The third generation chemotherapy drug in combing platonic regimen or sequential regimen in advanced non-small-cell lung cancer patients age ＞70,or with performance status 2[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 203-205. DOI: 10.3969/j.issn.1671-5144.2004.04.004
|
DownLoad: